“…This disease spectrum results from phenotypic heterogeneity of ZMPSTE24 mutations which result in varying degrees of enzyme activity (Barrowman, Wiley, Hudon‐miller, Hrycyna, & Michaelis, ). Those with little to no enzyme activity have the most severe of these disorders which is Restrictive Dermopathy (RD, OMIM #275210) (Ahmad et al, ; Happle et al, ; Kariminejad, Goodarzi, Thanh, & Wehnert, ; Li, ; Morais et al, ; Moulson et al ; Navarro et al, ; Navarro et al, ; Navarro et al, ; Yesil et al, ). Those with milder deficiency have the less severe disorder of Mandibuloacral Dysplasia with Type B Lipodystrophy (MADB, OMIM #608612) (Agarwal et al, ; Ahmad, Zackai, Medne, & Garg, ; Ben Yaou et al, ; Kwan, ; Miyoshi et al, ).…”